BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2230260)

  • 1. Partial characterization of Chlamydia trachomatis isolates resistant to multiple antibiotics.
    Jones RB; Van der Pol B; Martin DH; Shepard MK
    J Infect Dis; 1990 Dec; 162(6):1309-15. PubMed ID: 2230260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of antibiotics against Ureaplasma urealyticum and Chlamydia trachomatis strains from patients with nongonococcal urethritis.
    Busolo F; Conventi L
    Eur J Clin Microbiol Infect Dis; 1988 Jun; 7(3):407-10. PubMed ID: 3137045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative resistance to erythromycin in Chlamydia trachomatis.
    Mourad A; Sweet RL; Sugg N; Schachter J
    Antimicrob Agents Chemother; 1980 Nov; 18(5):696-8. PubMed ID: 7447426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Susceptibility study on urogenital Chlamydia trachomatis to 19 kinds of antibiotics].
    Bai H; Dong J; Ning B
    Zhonghua Yi Xue Za Zhi; 1995 Jan; 75(1):11-4, 60. PubMed ID: 7600311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibility of 7.5-kb common plasmid-free Chlamydia trachomatis strains.
    Miyashita N; Matsumoto A; Matsushima T
    Microbiol Immunol; 2000; 44(4):267-9. PubMed ID: 10832970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure.
    Somani J; Bhullar VB; Workowski KA; Farshy CE; Black CM
    J Infect Dis; 2000 Apr; 181(4):1421-7. PubMed ID: 10762573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and treatment of Chlamydia trachomatis, Ureaplasma urealyticum, and Mycoplasma hominis in patients with non-gonococcal urethritis.
    Kilic D; Basar MM; Kaygusuz S; Yilmaz E; Basar H; Batislam E
    Jpn J Infect Dis; 2004 Feb; 57(1):17-20. PubMed ID: 14985631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro activity of roxithromycin against Chlamydia trachomatis.
    Moroni A; Sambri V; Rumpianesi F; Donati M; Cevenini R
    J Chemother; 1991 Jan; 3 Suppl 1():28-9. PubMed ID: 12041779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative in vitro susceptibility of a tetracycline-resistant Chlamydia trachomatis strain isolated in Toulouse (France).
    Lefèvre JC; Lépargneur JP
    Sex Transm Dis; 1998 Aug; 25(7):350-2. PubMed ID: 9713914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nationwide surveillance of the antimicrobial susceptibility of Chlamydia trachomatis from male urethritis in Japan.
    Takahashi S; Hamasuna R; Yasuda M; Ishikawa K; Hayami H; Uehara S; Yamamoto S; Minamitani S; Kadota J; Iwata S; Kaku M; Watanabe A; Sato J; Hanaki H; Masumori N; Kiyota H; Egawa S; Tanaka K; Arakawa S; Fujisawa M; Kumon H; Wada K; Kobayashi K; Matsubara A; Matsumoto T; Eto M; Tatsugami K; Kuroiwa K; Ito K; Hosobe T; Hirayama H; Narita H; Yamaguchi T; Ito S; Sumii T; Kawai S; Kanokogi M; Kawano H; Chokyu H; Uno S; Monden K; Kaji S; Kawahara M; Takayama K; Ito M; Yoshioka M; Kano M; Konishi T; Kadena H; Nishi S; Nishimura H; Yamauchi T; Maeda S; Horie M; Ihara H; Matsumura M; Shirane T; Takeyama K; Akiyama K; Takahashi K; Ikuyama T; Inatomi H; Yoh M
    J Infect Chemother; 2016 Sep; 22(9):581-6. PubMed ID: 27452428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro evaluation of activities of azithromycin, erythromycin, and tetracycline against Chlamydia trachomatis and Chlamydia pneumoniae.
    Welsh LE; Gaydos CA; Quinn TC
    Antimicrob Agents Chemother; 1992 Feb; 36(2):291-4. PubMed ID: 1318677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of Chlamydia trachomatis to antibiotics in vitro and in vivo.
    Johannisson G; Sernryd A; Lycke E
    Sex Transm Dis; 1979; 6(2):50-7. PubMed ID: 494040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlamydia trachomatis clinical isolates identified as tetracycline resistant do not exhibit resistance in vitro: whole-genome sequencing reveals a mutation in porB but no evidence for tetracycline resistance genes.
    O'Neill CE; Seth-Smith HMB; Van Der Pol B; Harris SR; Thomson NR; Cutcliffe LT; Clarke IN
    Microbiology (Reading); 2013 Apr; 159(Pt 4):748-756. PubMed ID: 23378575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlamydia trachomatis: in vitro susceptibility of genital and ocular isolates to some quinolones, amoxicillin and azithromycin.
    Børsum T; Dannevig L; Størvold G; Melby K
    Chemotherapy; 1990; 36(6):407-15. PubMed ID: 1963393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Medical management of chronic Chlamydia trachomatis salpingitis resistant to usual antibiotics. Use of ofloxacin alone or combined with other anti-chlamydia antibiotics].
    Henry-Suchet J; Tannous W
    Contracept Fertil Sex; 1993 Sep; 21(9):627-9. PubMed ID: 8261008
    [No Abstract]   [Full Text] [Related]  

  • 16. In-vitro activity of fleroxacin against Chlamydia trachomatis.
    Steele-Mortimer O; Meier-Ewert H
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():65-70. PubMed ID: 3144551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genital Chlamydia trachomatis infection in women.
    Johannisson G; Löwhagen GB; Lycke E
    Obstet Gynecol; 1980 Dec; 56(6):671-5. PubMed ID: 6777719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bacterial flora in the urethra of men with Chlamydia trachomatis urethritis before and after treatment with ofloxacin].
    Ruczkowska J; Dolna I; Choroszy-Król I
    Przegl Dermatol; 1990; 77(3):186-92. PubMed ID: 2244013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uncommon occurrence of fluoroquinolone resistance-associated alterations in GyrA and ParC in clinical strains of Chlamydia trachomatis.
    Yokoi S; Yasuda M; Ito S; Takahashi Y; Ishihara S; Deguchi T; Maeda S; Kubota Y; Tamaki M; Fukushi H
    J Infect Chemother; 2004 Oct; 10(5):262-7. PubMed ID: 16163459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the in vitro susceptibility of clinical isolates of chlamydia trachomatis with serovar and duration of antibiotic exposure.
    Zheng H; Xue Y; Bai S; Qin X; Lu P; Yang B
    Sex Transm Dis; 2015 Mar; 42(3):115-9. PubMed ID: 25668641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.